Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trouw

Showing results (231-240 of 283) with videos related to

Pageof 29
Sort By:
Arthritis and Rheumatism|February 24, 2010
Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluidHans U Scherer, Diane van der Woude, Andreea Ioan-Facsinay, et al.
Annals of the Rheumatic Diseases|July 19, 2025
Development of bispecific antibodies that drive selective targeted local complement inhibition on rheumatoid arthritis-related antigensHaiyu Wang, Saskia Nugteren, Rick J Groenland, et al.
Arthritis and Rheumatism|April 21, 2011
The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigensAnnemiek Willemze, Diane van der Woude, Wendimagegn Ghidey, et al.
Arthritis Research & Therapy|June 2, 2017
The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identicalDebbie M Boeters, Lukas Mangnus, Sofia Ajeganova, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Reply to the correspondence on 'Development of bispecific antibodies that allow targeted local complement inhibition on rheumatoid arthritis related antigens'Haiyu Wang, Saskia Nugteren, Rick Groenland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2009
Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in miceMarielle A Otten, Tom W L Groeneveld, Roelof Flierman, et al.
European Journal of Immunology|January 29, 2022
Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cellsMieke F van Essen, Nicole Schlagwein, Elisa M P van den Hoven, et al.
Arthritis Research & Therapy|October 20, 2020
Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependencyTakeshi Iwasaki, Shuichiro Nakabo, Chikashi Terao, et al.
Arthritis and Rheumatism|December 2, 2011
Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritisP Suwannalai, L A van de Stadt, H Radner, et al.
Annals of the Rheumatic Diseases|July 27, 2018
In RA, becoming seronegative over the first year of treatment does not translate to better chances of drug-free remissionEmma C de Moel, Veerle F A M Derksen, Leendert A Trouw, et al.
Pageof 29

Showing results (231-240 of 283) with videos related to

Sort By:
Pageof 29
Arthritis and Rheumatism|February 24, 2010
Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluidHans U Scherer, Diane van der Woude, Andreea Ioan-Facsinay, et al.
Annals of the Rheumatic Diseases|July 19, 2025
Development of bispecific antibodies that drive selective targeted local complement inhibition on rheumatoid arthritis-related antigensHaiyu Wang, Saskia Nugteren, Rick J Groenland, et al.
Arthritis and Rheumatism|April 21, 2011
The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigensAnnemiek Willemze, Diane van der Woude, Wendimagegn Ghidey, et al.
Arthritis Research & Therapy|June 2, 2017
The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identicalDebbie M Boeters, Lukas Mangnus, Sofia Ajeganova, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Reply to the correspondence on 'Development of bispecific antibodies that allow targeted local complement inhibition on rheumatoid arthritis related antigens'Haiyu Wang, Saskia Nugteren, Rick Groenland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2009
Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in miceMarielle A Otten, Tom W L Groeneveld, Roelof Flierman, et al.
European Journal of Immunology|January 29, 2022
Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cellsMieke F van Essen, Nicole Schlagwein, Elisa M P van den Hoven, et al.
Arthritis Research & Therapy|October 20, 2020
Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependencyTakeshi Iwasaki, Shuichiro Nakabo, Chikashi Terao, et al.
Arthritis and Rheumatism|December 2, 2011
Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritisP Suwannalai, L A van de Stadt, H Radner, et al.
Annals of the Rheumatic Diseases|July 27, 2018
In RA, becoming seronegative over the first year of treatment does not translate to better chances of drug-free remissionEmma C de Moel, Veerle F A M Derksen, Leendert A Trouw, et al.
Pageof 29